世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

家庭用インスリンデリバリー(投与)機器の世界市場成長率 2022-2028


Global Home Insulin Delivery (Dosing) Devices Market Growth 2022-2028

世界経済の回復に伴い、家庭用インスリンデリバリー(投与)装置の2021年の成長は、前年から大きな変化を遂げるでしょう。弊社(LP Information)の最新調査によると、家庭用インスリンデリバリー(投与)装置の... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2022年4月20日 US$3,660
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
124 英語

 

サマリー

世界経済の回復に伴い、家庭用インスリンデリバリー(投与)装置の2021年の成長は、前年から大きな変化を遂げるでしょう。弊社(LP Information)の最新調査によると、家庭用インスリンデリバリー(投与)装置の世界市場規模は2021年の100万米ドルから2022年には100万米ドルとなり、2021年と2022年の間に%変化します。世界の家庭用インスリンデリバリー(投与)機器の市場規模は、2028年には百万米ドルに達し、分析期間2022年から2028年にかけて年平均成長率(%)で成長すると予測されます。
米国の家庭用インスリンデリバリー(投与)装置市場は、2021年に百万米ドルの価値があり、予測期間2022-2028年に約%のCAGRで成長すると予想されます。中国は、世界の家庭用インスリンデリバリー(投与)デバイス市場の % 市場を構成し、2028年までに100万米ドルに達します。ヨーロッパでは、ドイツが2028年までに100万ドルに達し、2022年から2028年の予測期間中にCAGRが%になると予測されています。APACでは、他の注目すべき市場(日本、韓国)の成長率は、今後6年間、それぞれ%と%と予測されています。
世界の主な家庭用インスリンデリバリー(投与)機器メーカーは、Tandem Diabetes Care、Biocon、Roche Holding AG、Insulet Corporationなどです。収益面では、世界の上位2社が2021年にほぼ%のシェアを占めています。
本レポートでは、家庭用インスリン送達(投与)装置市場の包括的な概要、市場シェア、成長機会を、製品タイプ、アプリケーション、主要メーカー、主要地域、国別に紹介します。
タイプ別区分:2.3項では2017年から2022年までの内訳データ、12.6項では2028年までの予測データ
インスリンペン
インスリンポンプ
インスリン注射器
その他
用途別セグメント:2017年から2022年までの内訳データは2.4項、2028年までの予測は12.7項。
病院薬局
オンライン薬局
小売薬局
また、本レポートでは、地域別に市場を分割しています。第4章、第5章、第6章、第7章、第8章における内訳データ。
米州
米国
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
また、本レポートでは、市場の競争環境と、それに対応する本市場の著名メーカーの詳細な分析も紹介しています。
タンデムダイアベッツケア
バイオコン
ロシュ・ホールディングAG
インスレット社
B. ブラウン
BD
イーライリリー・アンド・カンパニー
ノボ ノルディスク
サノフィ
ウォックハート
イプソメドホールディング
メドトロニック
ジュルファル
ベータ・バイオニクス
コペルニクス
ダンスバイオファーム
デビオテック
マンカインド
オーウェン マンフォード
ソイル
バレリータ
ウエストファーマ


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028
2.2 Home Insulin Delivery (Dosing) Devices Segment by Type
2.2.1 Insulin Pens
2.2.2 Insulin Pumps
2.2.3 Insulin Syringes
2.2.4 Others
2.3 Home Insulin Delivery (Dosing) Devices Sales by Type
2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022)
2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022)
2.4 Home Insulin Delivery (Dosing) Devices Segment by Application
2.4.1 Hospitals Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.5 Home Insulin Delivery (Dosing) Devices Sales by Application
2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022)
2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022)
2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022)
3 Global Home Insulin Delivery (Dosing) Devices by Company
3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company
3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022)
3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022)
3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022)
3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022)
3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022)
3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company
3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution
3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022)
4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region
4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022)
4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022)
4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region
4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth
4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth
4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth
4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth
5 Americas
5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country
5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type
5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region
6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022)
6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022)
6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type
6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Home Insulin Delivery (Dosing) Devices by Country
7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type
7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country
8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type
8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices
10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Home Insulin Delivery (Dosing) Devices Distributors
11.3 Home Insulin Delivery (Dosing) Devices Customer
12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region
12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028)
12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type
12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application
13 Key Players Analysis
13.1 Tandem Diabetes Care
13.1.1 Tandem Diabetes Care Company Information
13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered
13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Tandem Diabetes Care Main Business Overview
13.1.5 Tandem Diabetes Care Latest Developments
13.2 Biocon
13.2.1 Biocon Company Information
13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered
13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Biocon Main Business Overview
13.2.5 Biocon Latest Developments
13.3 Roche Holding AG
13.3.1 Roche Holding AG Company Information
13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered
13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Holding AG Main Business Overview
13.3.5 Roche Holding AG Latest Developments
13.4 Insulet Corporation
13.4.1 Insulet Corporation Company Information
13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered
13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Insulet Corporation Main Business Overview
13.4.5 Insulet Corporation Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered
13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered
13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Information
13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered
13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Eli Lilly and Company Main Business Overview
13.7.5 Eli Lilly and Company Latest Developments
13.8 Novo Nordisk
13.8.1 Novo Nordisk Company Information
13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered
13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novo Nordisk Main Business Overview
13.8.5 Novo Nordisk Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered
13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Wockhardt
13.10.1 Wockhardt Company Information
13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered
13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wockhardt Main Business Overview
13.10.5 Wockhardt Latest Developments
13.11 Ypsomed Holding
13.11.1 Ypsomed Holding Company Information
13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered
13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Ypsomed Holding Main Business Overview
13.11.5 Ypsomed Holding Latest Developments
13.12 Medtronic
13.12.1 Medtronic Company Information
13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered
13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Medtronic Main Business Overview
13.12.5 Medtronic Latest Developments
13.13 Julphar
13.13.1 Julphar Company Information
13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered
13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Julphar Main Business Overview
13.13.5 Julphar Latest Developments
13.14 Beta Bionics
13.14.1 Beta Bionics Company Information
13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered
13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Beta Bionics Main Business Overview
13.14.5 Beta Bionics Latest Developments
13.15 Copernicus
13.15.1 Copernicus Company Information
13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered
13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Copernicus Main Business Overview
13.15.5 Copernicus Latest Developments
13.16 Dance Biopharm
13.16.1 Dance Biopharm Company Information
13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered
13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dance Biopharm Main Business Overview
13.16.5 Dance Biopharm Latest Developments
13.17 Debiotech
13.17.1 Debiotech Company Information
13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered
13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Debiotech Main Business Overview
13.17.5 Debiotech Latest Developments
13.18 MannKind
13.18.1 MannKind Company Information
13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered
13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 MannKind Main Business Overview
13.18.5 MannKind Latest Developments
13.19 Owen Mumford
13.19.1 Owen Mumford Company Information
13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered
13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Owen Mumford Main Business Overview
13.19.5 Owen Mumford Latest Developments
13.20 SOOIL
13.20.1 SOOIL Company Information
13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered
13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 SOOIL Main Business Overview
13.20.5 SOOIL Latest Developments
13.21 Valeritas
13.21.1 Valeritas Company Information
13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered
13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Valeritas Main Business Overview
13.21.5 Valeritas Latest Developments
13.22 West Pharma
13.22.1 West Pharma Company Information
13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered
13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 West Pharma Main Business Overview
13.22.5 West Pharma Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

As the global economy mends, the 2021 growth of Home Insulin Delivery (Dosing) Devices will have significant change from previous year. According to our (LP Information) latest study, the global Home Insulin Delivery (Dosing) Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Home Insulin Delivery (Dosing) Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Home Insulin Delivery (Dosing) Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Home Insulin Delivery (Dosing) Devices market, reaching US$ million by the year 2028. As for the Europe Home Insulin Delivery (Dosing) Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Home Insulin Delivery (Dosing) Devices players cover Tandem Diabetes Care, Biocon, Roche Holding AG, and Insulet Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Home Insulin Delivery (Dosing) Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028
2.2 Home Insulin Delivery (Dosing) Devices Segment by Type
2.2.1 Insulin Pens
2.2.2 Insulin Pumps
2.2.3 Insulin Syringes
2.2.4 Others
2.3 Home Insulin Delivery (Dosing) Devices Sales by Type
2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022)
2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022)
2.4 Home Insulin Delivery (Dosing) Devices Segment by Application
2.4.1 Hospitals Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.5 Home Insulin Delivery (Dosing) Devices Sales by Application
2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022)
2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022)
2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022)
3 Global Home Insulin Delivery (Dosing) Devices by Company
3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company
3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022)
3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022)
3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022)
3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022)
3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022)
3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company
3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution
3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022)
4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region
4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022)
4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022)
4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region
4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth
4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth
4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth
4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth
5 Americas
5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country
5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type
5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region
6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022)
6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022)
6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type
6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Home Insulin Delivery (Dosing) Devices by Country
7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type
7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country
8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type
8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices
10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Home Insulin Delivery (Dosing) Devices Distributors
11.3 Home Insulin Delivery (Dosing) Devices Customer
12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region
12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028)
12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type
12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application
13 Key Players Analysis
13.1 Tandem Diabetes Care
13.1.1 Tandem Diabetes Care Company Information
13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered
13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Tandem Diabetes Care Main Business Overview
13.1.5 Tandem Diabetes Care Latest Developments
13.2 Biocon
13.2.1 Biocon Company Information
13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered
13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Biocon Main Business Overview
13.2.5 Biocon Latest Developments
13.3 Roche Holding AG
13.3.1 Roche Holding AG Company Information
13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered
13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Holding AG Main Business Overview
13.3.5 Roche Holding AG Latest Developments
13.4 Insulet Corporation
13.4.1 Insulet Corporation Company Information
13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered
13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Insulet Corporation Main Business Overview
13.4.5 Insulet Corporation Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered
13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered
13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Information
13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered
13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Eli Lilly and Company Main Business Overview
13.7.5 Eli Lilly and Company Latest Developments
13.8 Novo Nordisk
13.8.1 Novo Nordisk Company Information
13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered
13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Novo Nordisk Main Business Overview
13.8.5 Novo Nordisk Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered
13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Wockhardt
13.10.1 Wockhardt Company Information
13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered
13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wockhardt Main Business Overview
13.10.5 Wockhardt Latest Developments
13.11 Ypsomed Holding
13.11.1 Ypsomed Holding Company Information
13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered
13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Ypsomed Holding Main Business Overview
13.11.5 Ypsomed Holding Latest Developments
13.12 Medtronic
13.12.1 Medtronic Company Information
13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered
13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Medtronic Main Business Overview
13.12.5 Medtronic Latest Developments
13.13 Julphar
13.13.1 Julphar Company Information
13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered
13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Julphar Main Business Overview
13.13.5 Julphar Latest Developments
13.14 Beta Bionics
13.14.1 Beta Bionics Company Information
13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered
13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Beta Bionics Main Business Overview
13.14.5 Beta Bionics Latest Developments
13.15 Copernicus
13.15.1 Copernicus Company Information
13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered
13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Copernicus Main Business Overview
13.15.5 Copernicus Latest Developments
13.16 Dance Biopharm
13.16.1 Dance Biopharm Company Information
13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered
13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dance Biopharm Main Business Overview
13.16.5 Dance Biopharm Latest Developments
13.17 Debiotech
13.17.1 Debiotech Company Information
13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered
13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Debiotech Main Business Overview
13.17.5 Debiotech Latest Developments
13.18 MannKind
13.18.1 MannKind Company Information
13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered
13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 MannKind Main Business Overview
13.18.5 MannKind Latest Developments
13.19 Owen Mumford
13.19.1 Owen Mumford Company Information
13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered
13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Owen Mumford Main Business Overview
13.19.5 Owen Mumford Latest Developments
13.20 SOOIL
13.20.1 SOOIL Company Information
13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered
13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 SOOIL Main Business Overview
13.20.5 SOOIL Latest Developments
13.21 Valeritas
13.21.1 Valeritas Company Information
13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered
13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Valeritas Main Business Overview
13.21.5 Valeritas Latest Developments
13.22 West Pharma
13.22.1 West Pharma Company Information
13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered
13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 West Pharma Main Business Overview
13.22.5 West Pharma Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(電子部品/半導体)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る